The phagocyte specific protein S100A12 as a novel biomarker in Muckle-Wells-Syndrome before and during therapy with Anakinra and Canakinumab (ACZ885)

The phagocyte specific protein S100A12 as a novel biomarker in Muckle-Wells-Syndrome before and during therapy with Anakinra and Canakinumab (ACZ885)

Bibliographic Details
Main Authors: Wittkowski, H, Kuemmerle-Deschner, JB, Gramlich, K, Tzaribachev, N, Felix, SD, Jung, T, Roth, J, Rordorf, C, Foell, D
Format: Online
Language:English
Published: BioMed Central 2008
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334013/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334013/

Similar Items